Following points are presented in this presentation.
1. Hypothesis testing is a decision-making process for evaluating claims about a population.
2. NULL HYPOTHESIS & ALTERNATIVE HYPOTHESIS.
3. Types of errors.
This presentation discusses the following topics:
Hypothesis Test
Potential Outcomes in Hypothesis Testing
Significance level
P-value
Sampling Errors
Type I Error
What causes Type I errors?
What causes Type II errors?
4 possible outcomes
Following points are presented in this presentation.
1. Hypothesis testing is a decision-making process for evaluating claims about a population.
2. NULL HYPOTHESIS & ALTERNATIVE HYPOTHESIS.
3. Types of errors.
This presentation discusses the following topics:
Hypothesis Test
Potential Outcomes in Hypothesis Testing
Significance level
P-value
Sampling Errors
Type I Error
What causes Type I errors?
What causes Type II errors?
4 possible outcomes
Mathematics in Epidemiology and Biostatistics (Medical Booklet Series by Dr. ...Dr. Aryan (Anish Dhakal)
Basic mathematics needed for epidemiology and bio statistics. Slides include formulas and conceptual understanding of sensitivity, specificity, predictive values, likelihood ratios, odds, probability and many more.
What is the significance of p value while reporting statistical analysis. Is there an alternate approach for Fisher, if so what is that approach. These are some of the issues addressed here.
The number that divides the normal distribution into region where we will reject the null hypothesis and the region where we fail to reject the null hypothesis. For normal distribution Z at 5% level of significance (z= plus-minus 1.96) is often referred to as the critical value (or critical region).
Mathematics in Epidemiology and Biostatistics (Medical Booklet Series by Dr. ...Dr. Aryan (Anish Dhakal)
Basic mathematics needed for epidemiology and bio statistics. Slides include formulas and conceptual understanding of sensitivity, specificity, predictive values, likelihood ratios, odds, probability and many more.
What is the significance of p value while reporting statistical analysis. Is there an alternate approach for Fisher, if so what is that approach. These are some of the issues addressed here.
The number that divides the normal distribution into region where we will reject the null hypothesis and the region where we fail to reject the null hypothesis. For normal distribution Z at 5% level of significance (z= plus-minus 1.96) is often referred to as the critical value (or critical region).
This is a crash course in A/B testing from the statistical view. Focus is placed on the overall idea and framework assuming very little experience/knowledge in statistics.
Chris Stuccio - Data science - Conversion Hotel 2015Webanalisten .nl
Slides of the keynote by Chris Stuccio (USA) at Conversion Hotel 2015, Texel, the Netherlands (#CH2015): "What’s this all about data science? Explain baysian statistics to me as a kid – what should I know?" http://conversionhotel.com
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
1. Hypothesis Testing & p-value
Dr. Athar Khan
MBBS, MCPS, DPH, MBA, DCPS-HPE, DCPS-HCSM,
PGD-Statistics, BA, MA, PhD Scholar
Associate Professor
Department of Community Medicine
Liaquat College of Medicine & Dentistry
matharm@yahoo.com
2. CHAPTER # of BCQ’s #EMQ’s
General epidemiology and screening 9 1
Demography and population dynamics 7 1
Biostatistics 5 1
TOTAL MARKS 21 3
3. HYPOTHESIS
• Any statement about a population is termed as
hypothesis. OR
• A hypothesis is an educated guess or proposition
that attempts to explain a set of facts or natural
phenomenon. OR
• A hypothesis is a proposed explanation for a
phenomenon.
4. HYPOTHESIS
• Null Hypothesis(Ho) : There is NO difference or
association or relationship between the abdominal
and vaginal hysterectomy with respect to post
operative complications
• Alternate Hypothesis (Ha/H1) : There is a difference or
association or relationship between the abdominal
and vaginal hysterectomy with respect to post
operative complications
5. ALTERNATIVE HYPOTHESIS
• Alternative hypothesis is generally the research
question or researcher hypothesis.
• Null hypothesis is usually against the claim of the
researcher and every researcher would like to reject
this hypothesis
6. ALTERNATIVE HYPOTHESIS
• There is difference in complications between AH
and VH (Two Tailed/Two sided)
• VH has less complications than AH (One
Tailed/One sided)
• VH has more complications than AH (One
Tailed/One sided)
7. ALTERNATIVE HYPOTHESIS
• Our final decision is based on to:
– Reject the Null Hypothesis
– Fail to reject (accept) the Null Hypothesis
9. SITUATION ONE:
REJECT THE NULL HYPOTHESIS
TRUE SITUATION NULL HYPOTHESIS DECISION
REJECT Ho REJECTED RIGHT √
REJECT Ho NOT REJECTED WRONG
10. SITUATION TWO
FAIL TO REJECT THE NULL HYPOTHESIS
TRUE SITUATION NULL HYPOTHESIS DECISION
FAIL TO REJECT Ho NOT REJECTED RIGHT √
FAIL TO REJECT Ho REJECTED WRONG
11. • We make decision in research on the basis of
available evidence.
• Are we 100% sure?
• Is there a chance of error in our decision?
• Maximum 5% (0.05) is reasonable in making decision
about Ho. Sometimes 10% (0.1) and more accurate
1% (0.01) may be considered.
12. LEVEL OF SIGNIFICANCE OR Alpha
• The chance of error which is set before starting
experiment and is fixed at 1%, 5%,10% is known as
level of significance of Alpha
• 0.01 probability = 1%
• 0.05 probability = 5%
• 0.1 probability = 10%
MOST COMMON
13. CONFIDENCE LEVEL
Confidence Level = 1 – α
If α = 0.05
Confidence Level = 1 – α
Confidence Level = 1 – 0.05
Confidence Level = 0.95 or 95%
If α = 0.01 and α = 0.1
MOST COMMON
15. TYPES OF ERRORS
DESIRE OF RESEARCHER IS TO REJECT Ho
TRUE SITUATION
DECISION Ho TRUE Ho FALSE
REJECT Ho Type I error or α error CORRECT
Fail to reject (accept) Ho CORRECT Type II error or β error
Type I error - α error (RTA):
Rejecting Ho when actually it is true.
Type II error - β error (AFB):
Fail to reject Ho when actually it is false.
16. What is Power of a Test?
– Power = P(reject null | null is false)
– It is the probability of rejecting Ho when Ho is indeed
false.
Power = 1 – β
If β = 20 then 1 – β = 80% so that we would have
rejected the false Ho about 80% of the time.
17. Hints for BCQ’s
– Alpha error s serious than Beta error
– Alpha error 5%(0.05) or less is acceptable
– Beta error 20%(0.20) or less is acceptable
– Power of the study 80%(0.80) or more is acceptable
19. DEFINITION
• Probability of committing Type I error OR
• Probability of rejecting Ho when actually it is true
OR
• Probability of falsely rejecting Ho OR
• Probability of getting a result by chance
• P-Values range from 0 to 1
20. P value and Significance level
• Level of significance is set before starting the
experiment and is fixed at 1%, 5%, 10% but P value
is calculated after completing the experiment and it
is not fixed.
• If p value is less than will reject Ho and if it is
more than we will not reject Ho.
21. Interpreting p value
P value Inter pretation
P > 0.05 Result is not statistically significant
P < 0.05
Result is statistically significant *
<5% of committing Type I error
95% confident that real difference or not due to
chance
P < 0.01 Result is highly statistically significant **
P < 0.001
Result is very highly statistically significant ***
MOST COMMON